Acta Oncologica

Papers
(The H4-Index of Acta Oncologica is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
A study of microRNAs as new prognostic biomarkers in anal cancer patients48
The first decade of the Danish Palliative Care Database: improvements and ongoing challenges in the quality and use of specialised palliative care45
Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI36
Methylphenidate for treating fatigue in palliative cancer care – effect and side effects in real-world data from a palliative care unit34
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–201730
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact26
Use of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data26
A biomarker panel predicts recurrence-free survival in ulcerated primary cutaneous melanoma25
Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature24
Malignancy rates of salivary gland tumors in Greenlandic Inuit comparable to non-endemic populations; epidemiological mapping of salivary gland tumors 1990–201923
Socioeconomic inequality in cancer in the Nordic countries. A systematic review22
Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac21
Health-Related Quality of Life in Danish Cancer Survivors Referred to a Late Effects Clinic: A Prospective Cohort Study21
Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment21
Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry20
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study19
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric features18
Evaluation of in vitro irradiation setup: Designed for the horizontal beamline at the Danish Centre for Particle Therapy18
0.15934801101685